Azithromycin Dosing for Legionnaires' Disease

Treatment Regimens

The Infectious Diseases Society of America recommends azithromycin 500 mg intravenously daily for 2-7 days, followed by oral azithromycin to complete a total course of 7-10 days for hospitalized patients with Legionnaires' disease 1, 2
For non-hospitalized patients with mild disease, the recommended oral regimen is azithromycin 500 mg on day 1, followed by 250 mg daily for 4 additional days 1, 2

Fluoroquinolones, such as levofloxacin, moxifloxacin, and gatifloxacin, are effective alternatives for patients who cannot tolerate macrolides, according to the Infectious Diseases Society of America 1, 2
Other acceptable antibiotics for non-hospitalized patients include erythromycin, doxycycline, or clarithromycin, as suggested by the Infectious Diseases Society of America 1, 2

The Infectious Diseases Society of America recommends initiating treatment as rapidly as possible after diagnosis, as delay in therapy is associated with increased mortality 3
Treatment for Legionnaires' disease is appropriate even when diagnostic test results are negative if there is strong epidemiologic evidence of this disease, according to the Infectious Diseases Society of America 1, 2

Patients with moderate-to-severe disease should be monitored closely during therapy to ensure clinical improvement, as recommended by the Infectious Diseases Society of America 4
Clinical improvement should typically occur within 48-72 hours after initiating appropriate therapy, according to the Infectious Diseases Society of America 4

Legionnaires' disease can be difficult to distinguish from other causes of pneumonia based on clinical findings alone, highlighting the importance of empiric coverage in severe community-acquired pneumonia 3
Delay in appropriate therapy is associated with increased mortality, so empiric coverage should be considered in severe community-acquired pneumonia, as recommended by the Infectious Diseases Society of America 3, 2
No laboratory test for Legionnaires' disease detects all cases, so therapy should be continued in appropriate clinical settings even if specific tests are negative, according to the Infectious Diseases Society of America 3